viral infection in critical care unit lecture 2013
TRANSCRIPT
![Page 1: Viral infection in critical care unit lecture 2013](https://reader036.vdocuments.site/reader036/viewer/2022062703/55567338d8b42a144c8b526b/html5/thumbnails/1.jpg)
Viral infection in Critical Care unit
SMR.Hashemian MD.FCCM
Associate professor of SBMU/NRITLD
![Page 2: Viral infection in critical care unit lecture 2013](https://reader036.vdocuments.site/reader036/viewer/2022062703/55567338d8b42a144c8b526b/html5/thumbnails/2.jpg)
WHY IS THIS IMPORTANT?
• Most infections are caused by viruses.• Health care professionals must understand
the pathogenic mechanisms used by these pathogens.
![Page 3: Viral infection in critical care unit lecture 2013](https://reader036.vdocuments.site/reader036/viewer/2022062703/55567338d8b42a144c8b526b/html5/thumbnails/3.jpg)
PATTERNS OF VIRAL INFECTION
• Viral infections can be:• Acute (rapid and self limiting)• Persistent (long term)• Latent (extreme versions of persistent
infections)• Slow or transforming (complicated
types of persistent infections)
![Page 4: Viral infection in critical care unit lecture 2013](https://reader036.vdocuments.site/reader036/viewer/2022062703/55567338d8b42a144c8b526b/html5/thumbnails/4.jpg)
PATTERNS OF VIRAL INFECTION
• Cytopathic viruses produce virions and kill host cells rapidly (cytopathology).
• Noncytopathic viruses produce virions but do not cause cytopathology.
![Page 5: Viral infection in critical care unit lecture 2013](https://reader036.vdocuments.site/reader036/viewer/2022062703/55567338d8b42a144c8b526b/html5/thumbnails/5.jpg)
PATTERNS OF VIRAL INFECTION
• Incubation periods vary for different viruses.• Some are as short as days.• Some are as long as years.• During the incubation period:• The virus is replicating.• The host is beginning to respond
![Page 6: Viral infection in critical care unit lecture 2013](https://reader036.vdocuments.site/reader036/viewer/2022062703/55567338d8b42a144c8b526b/html5/thumbnails/6.jpg)
PATTERNS OF VIRAL INFECTION
![Page 7: Viral infection in critical care unit lecture 2013](https://reader036.vdocuments.site/reader036/viewer/2022062703/55567338d8b42a144c8b526b/html5/thumbnails/7.jpg)
Microbiology: A Clinical Approach © Garland Science
ACUTE INFECTIONS
![Page 8: Viral infection in critical care unit lecture 2013](https://reader036.vdocuments.site/reader036/viewer/2022062703/55567338d8b42a144c8b526b/html5/thumbnails/8.jpg)
VIRAL DISSEMINATION
The three main entry points are:• Respiratory system• Digestive tract• Urogenital tract
• Viruses easily disseminate from here into other areas of the body.
![Page 9: Viral infection in critical care unit lecture 2013](https://reader036.vdocuments.site/reader036/viewer/2022062703/55567338d8b42a144c8b526b/html5/thumbnails/9.jpg)
ICU Care is Invasive
More invasive lines and procedures including surgeries
Longer length of stay
More IV and parenteral drugs
More tube feeding and Parenteral nutrition
More ventilation
![Page 10: Viral infection in critical care unit lecture 2013](https://reader036.vdocuments.site/reader036/viewer/2022062703/55567338d8b42a144c8b526b/html5/thumbnails/10.jpg)
![Page 11: Viral infection in critical care unit lecture 2013](https://reader036.vdocuments.site/reader036/viewer/2022062703/55567338d8b42a144c8b526b/html5/thumbnails/11.jpg)
![Page 12: Viral infection in critical care unit lecture 2013](https://reader036.vdocuments.site/reader036/viewer/2022062703/55567338d8b42a144c8b526b/html5/thumbnails/12.jpg)
![Page 13: Viral infection in critical care unit lecture 2013](https://reader036.vdocuments.site/reader036/viewer/2022062703/55567338d8b42a144c8b526b/html5/thumbnails/13.jpg)
![Page 14: Viral infection in critical care unit lecture 2013](https://reader036.vdocuments.site/reader036/viewer/2022062703/55567338d8b42a144c8b526b/html5/thumbnails/14.jpg)
![Page 15: Viral infection in critical care unit lecture 2013](https://reader036.vdocuments.site/reader036/viewer/2022062703/55567338d8b42a144c8b526b/html5/thumbnails/15.jpg)
![Page 16: Viral infection in critical care unit lecture 2013](https://reader036.vdocuments.site/reader036/viewer/2022062703/55567338d8b42a144c8b526b/html5/thumbnails/16.jpg)
![Page 17: Viral infection in critical care unit lecture 2013](https://reader036.vdocuments.site/reader036/viewer/2022062703/55567338d8b42a144c8b526b/html5/thumbnails/17.jpg)
![Page 18: Viral infection in critical care unit lecture 2013](https://reader036.vdocuments.site/reader036/viewer/2022062703/55567338d8b42a144c8b526b/html5/thumbnails/18.jpg)
![Page 19: Viral infection in critical care unit lecture 2013](https://reader036.vdocuments.site/reader036/viewer/2022062703/55567338d8b42a144c8b526b/html5/thumbnails/19.jpg)
![Page 20: Viral infection in critical care unit lecture 2013](https://reader036.vdocuments.site/reader036/viewer/2022062703/55567338d8b42a144c8b526b/html5/thumbnails/20.jpg)
![Page 21: Viral infection in critical care unit lecture 2013](https://reader036.vdocuments.site/reader036/viewer/2022062703/55567338d8b42a144c8b526b/html5/thumbnails/21.jpg)
![Page 22: Viral infection in critical care unit lecture 2013](https://reader036.vdocuments.site/reader036/viewer/2022062703/55567338d8b42a144c8b526b/html5/thumbnails/22.jpg)
![Page 23: Viral infection in critical care unit lecture 2013](https://reader036.vdocuments.site/reader036/viewer/2022062703/55567338d8b42a144c8b526b/html5/thumbnails/23.jpg)
![Page 24: Viral infection in critical care unit lecture 2013](https://reader036.vdocuments.site/reader036/viewer/2022062703/55567338d8b42a144c8b526b/html5/thumbnails/24.jpg)
HIV006.gif
![Page 25: Viral infection in critical care unit lecture 2013](https://reader036.vdocuments.site/reader036/viewer/2022062703/55567338d8b42a144c8b526b/html5/thumbnails/25.jpg)
![Page 26: Viral infection in critical care unit lecture 2013](https://reader036.vdocuments.site/reader036/viewer/2022062703/55567338d8b42a144c8b526b/html5/thumbnails/26.jpg)
![Page 27: Viral infection in critical care unit lecture 2013](https://reader036.vdocuments.site/reader036/viewer/2022062703/55567338d8b42a144c8b526b/html5/thumbnails/27.jpg)
What is MERSWhat is MERS CDC continues to work closely
with the World Health Organization (WHO) and other partners to better understand the public health risk presented by Middle East Respiratory Syndrome Coronavirus (MERS-CoV). MERS-CoV used to be called “novel coronavirus,” or “nCoV
![Page 28: Viral infection in critical care unit lecture 2013](https://reader036.vdocuments.site/reader036/viewer/2022062703/55567338d8b42a144c8b526b/html5/thumbnails/28.jpg)
Is this virus the same Is this virus the same as the SARS virus?as the SARS virus?
No. The novel coronavirus is not the same virus that caused severe acute respiratory syndrome (SARS) in 2003. However, like the SARS virus, the novel coronavirus is most similar to those found in bats. CDC is still learning about this new virus.
![Page 29: Viral infection in critical care unit lecture 2013](https://reader036.vdocuments.site/reader036/viewer/2022062703/55567338d8b42a144c8b526b/html5/thumbnails/29.jpg)
MERS Cases and MERS Cases and Deaths,Deaths,April 2012 - May 2013April 2012 - May 2013
Current as of June 11, 2013 Countries Cases (Deaths) France 2 (1) Italy 3 (0) Jordan 2 (2) Qatar 2 (0)
Saudi Arabia 40 (26) Tunisia 2 (0) United Kingdom (UK) 3 (2) United Arab Emirates (UAE) 1 (1)
Total 55 (32)
![Page 30: Viral infection in critical care unit lecture 2013](https://reader036.vdocuments.site/reader036/viewer/2022062703/55567338d8b42a144c8b526b/html5/thumbnails/30.jpg)
Countries Cases (Deaths)
France 2 (1)
Italy 3 (0)
Jordan 2 (2)
Qatar 2 (0)
Saudi Arabia 53 (32)
Tunisia 2 (0)
United Kingdom (UK) 3 (2)
United Arab Emirates (UAE) 1 (1)
Total 68 (38)
![Page 31: Viral infection in critical care unit lecture 2013](https://reader036.vdocuments.site/reader036/viewer/2022062703/55567338d8b42a144c8b526b/html5/thumbnails/31.jpg)
![Page 32: Viral infection in critical care unit lecture 2013](https://reader036.vdocuments.site/reader036/viewer/2022062703/55567338d8b42a144c8b526b/html5/thumbnails/32.jpg)
Australian and New Zealand Intensive Care (ANZIC)
![Page 33: Viral infection in critical care unit lecture 2013](https://reader036.vdocuments.site/reader036/viewer/2022062703/55567338d8b42a144c8b526b/html5/thumbnails/33.jpg)
IntroductionIntroduction
2009 H1N1 influenza (WHO, 2009/9/6) 2009 H1N1 influenza (WHO, 2009/9/6) Laboratory-confirmed cases: over 277,607 Laboratory-confirmed cases: over 277,607 Death: at least 3205 Death: at least 3205
2009/6~2009/8, Australia and New Zealand2009/6~2009/8, Australia and New Zealand Combined effect of the pandemic and Combined effect of the pandemic and winterwinter Incidence of infection was 8 times of the US Incidence of infection was 8 times of the US Population-based data Population-based data
![Page 34: Viral infection in critical care unit lecture 2013](https://reader036.vdocuments.site/reader036/viewer/2022062703/55567338d8b42a144c8b526b/html5/thumbnails/34.jpg)
Methods Methods Multicenter inception-cohort study Multicenter inception-cohort study
involving involving 187 ICUs187 ICUs All the ICUs (adult or pediatric) in the All the ICUs (adult or pediatric) in the two countriestwo countries 1879 beds; 1449 were equipped for 1879 beds; 1449 were equipped for ventilator ventilator
Patients admitted to the ICU with Patients admitted to the ICU with confirmedconfirmed 2009 H1N1 influenza 2009 H1N1 influenza 2009/6/1~2009/8/31 2009/6/1~2009/8/31 PCR assay PCR assay Serologic analysis Serologic analysis
![Page 35: Viral infection in critical care unit lecture 2013](https://reader036.vdocuments.site/reader036/viewer/2022062703/55567338d8b42a144c8b526b/html5/thumbnails/35.jpg)
Australia: 626Australia: 626 New Zealand: New Zealand: 9696
oViral pneumonitis: Viral pneumonitis: 2005: 57 2005: 57 2006: 33 2006: 33 2007: 69 2007: 69 2008: 69 2008: 69 mean: 57 patients mean: 57 patients
Incidence of ICU Incidence of ICU admission: admission: 28.7 per million 28.7 per million inhabitantsinhabitants
ResultsResults
![Page 36: Viral infection in critical care unit lecture 2013](https://reader036.vdocuments.site/reader036/viewer/2022062703/55567338d8b42a144c8b526b/html5/thumbnails/36.jpg)
Mechanical ventilation: Mechanical ventilation: 456/706 patients (64.6%) 456/706 patients (64.6%) median of 8 days median of 8 days total number of days of MV: 5249 days total number of days of MV: 5249 days (208 days per million inhabitants) (208 days per million inhabitants) 53/456 patients (11.6%) subsequence 53/456 patients (11.6%) subsequence with ECMO with ECMO (2.1 patients per million inhabitants) (2.1 patients per million inhabitants)
![Page 37: Viral infection in critical care unit lecture 2013](https://reader036.vdocuments.site/reader036/viewer/2022062703/55567338d8b42a144c8b526b/html5/thumbnails/37.jpg)
Median duration of ICU stay: 7.4 daysMedian duration of ICU stay: 7.4 days Median duration of hospital stay: 12.3 daysMedian duration of hospital stay: 12.3 days
(Exclude the 114 patients and an additional 33 for whom data (Exclude the 114 patients and an additional 33 for whom data were not available)were not available)
![Page 38: Viral infection in critical care unit lecture 2013](https://reader036.vdocuments.site/reader036/viewer/2022062703/55567338d8b42a144c8b526b/html5/thumbnails/38.jpg)
ICU occupied:ICU occupied:
8815 ICU bed-days 8815 ICU bed-days 350 bed-days per million 350 bed-days per million inhabitants inhabitants
Over the 3-month study period, 5.2% Over the 3-month study period, 5.2% of ICU bed-days were accounted for of ICU bed-days were accounted for by patients with 2009 H1N1 by patients with 2009 H1N1 influenza.influenza.
![Page 39: Viral infection in critical care unit lecture 2013](https://reader036.vdocuments.site/reader036/viewer/2022062703/55567338d8b42a144c8b526b/html5/thumbnails/39.jpg)
MortalityMortality In-hospital mortality: exceed 16% In-hospital mortality: exceed 16%
no higher than patients with seasonal influenza A no higher than patients with seasonal influenza A who were admitted to an ICU who were admitted to an ICU
Poor prognostic factor:Poor prognostic factor: Older age Older age A requirement for invasive ventilation A requirement for invasive ventilation Presence of coexisting conditions Presence of coexisting conditions > 16 y/o: higher APACHE III scores > 16 y/o: higher APACHE III scores < 16 y/o: prematurity, immunodeficiency, cystic < 16 y/o: prematurity, immunodeficiency, cystic fibrosis, congenital heart disease, fibrosis, congenital heart disease, neuromuscular disorder, or chronic neuromuscular disorder, or chronic neurological impairment; neurological impairment; asthma, chronic pulmonary disease, chronic asthma, chronic pulmonary disease, chronic heart heart failure, DM failure, DM
![Page 40: Viral infection in critical care unit lecture 2013](https://reader036.vdocuments.site/reader036/viewer/2022062703/55567338d8b42a144c8b526b/html5/thumbnails/40.jpg)
![Page 41: Viral infection in critical care unit lecture 2013](https://reader036.vdocuments.site/reader036/viewer/2022062703/55567338d8b42a144c8b526b/html5/thumbnails/41.jpg)
![Page 42: Viral infection in critical care unit lecture 2013](https://reader036.vdocuments.site/reader036/viewer/2022062703/55567338d8b42a144c8b526b/html5/thumbnails/42.jpg)
![Page 43: Viral infection in critical care unit lecture 2013](https://reader036.vdocuments.site/reader036/viewer/2022062703/55567338d8b42a144c8b526b/html5/thumbnails/43.jpg)
![Page 44: Viral infection in critical care unit lecture 2013](https://reader036.vdocuments.site/reader036/viewer/2022062703/55567338d8b42a144c8b526b/html5/thumbnails/44.jpg)
![Page 45: Viral infection in critical care unit lecture 2013](https://reader036.vdocuments.site/reader036/viewer/2022062703/55567338d8b42a144c8b526b/html5/thumbnails/45.jpg)
2010from 23 June
2009 through 11 February 2010
![Page 46: Viral infection in critical care unit lecture 2013](https://reader036.vdocuments.site/reader036/viewer/2022062703/55567338d8b42a144c8b526b/html5/thumbnails/46.jpg)
220 admitted to anintensive care unit (ICU)
with completed outcome data were analyzed.
Invasive mechanical ventilation was
used in 155 (70.5%). Sixty-seven (30.5%) of the
patients died in ICU and
![Page 47: Viral infection in critical care unit lecture 2013](https://reader036.vdocuments.site/reader036/viewer/2022062703/55567338d8b42a144c8b526b/html5/thumbnails/47.jpg)
![Page 48: Viral infection in critical care unit lecture 2013](https://reader036.vdocuments.site/reader036/viewer/2022062703/55567338d8b42a144c8b526b/html5/thumbnails/48.jpg)
Survival graph
![Page 49: Viral infection in critical care unit lecture 2013](https://reader036.vdocuments.site/reader036/viewer/2022062703/55567338d8b42a144c8b526b/html5/thumbnails/49.jpg)
Cox regression analysis
adjusted for severity and potential confounding factors identified that early use of corticosteroids was not significantly
![Page 50: Viral infection in critical care unit lecture 2013](https://reader036.vdocuments.site/reader036/viewer/2022062703/55567338d8b42a144c8b526b/html5/thumbnails/50.jpg)
VIRAL INFECTIONS OF THE RESPIRATORY TRACT
Influenza virus Rhinovirus Coronavirus
Parainfluenza viruses
Respiratory Syncytial viruses
Adenovirus Coxsackievirus
![Page 51: Viral infection in critical care unit lecture 2013](https://reader036.vdocuments.site/reader036/viewer/2022062703/55567338d8b42a144c8b526b/html5/thumbnails/51.jpg)
![Page 52: Viral infection in critical care unit lecture 2013](https://reader036.vdocuments.site/reader036/viewer/2022062703/55567338d8b42a144c8b526b/html5/thumbnails/52.jpg)
![Page 53: Viral infection in critical care unit lecture 2013](https://reader036.vdocuments.site/reader036/viewer/2022062703/55567338d8b42a144c8b526b/html5/thumbnails/53.jpg)
![Page 54: Viral infection in critical care unit lecture 2013](https://reader036.vdocuments.site/reader036/viewer/2022062703/55567338d8b42a144c8b526b/html5/thumbnails/54.jpg)
![Page 55: Viral infection in critical care unit lecture 2013](https://reader036.vdocuments.site/reader036/viewer/2022062703/55567338d8b42a144c8b526b/html5/thumbnails/55.jpg)
Viral infections in the ICU
![Page 56: Viral infection in critical care unit lecture 2013](https://reader036.vdocuments.site/reader036/viewer/2022062703/55567338d8b42a144c8b526b/html5/thumbnails/56.jpg)
Nosocomial viral disease
Herpesviridae HSV CMV
Respiratory viruses Influenza, Rhinovirus, RSV,
Adenovirus, etc.
![Page 57: Viral infection in critical care unit lecture 2013](https://reader036.vdocuments.site/reader036/viewer/2022062703/55567338d8b42a144c8b526b/html5/thumbnails/57.jpg)
Herpes Simplex
General population (saliva): 1-5% ICU patients: 22% In a recent study on 201 non
immunocompromised patients ventilated for at least 5 days, HSV was detected in the throat of 109 patients (54%) 44% symptomatic
![Page 58: Viral infection in critical care unit lecture 2013](https://reader036.vdocuments.site/reader036/viewer/2022062703/55567338d8b42a144c8b526b/html5/thumbnails/58.jpg)
Herpes simplex virus often produces sharply demarcated ulcerations in oral, esophageal, or perianal regions. Here is the edge of an
ulcer seen microscopically.
![Page 59: Viral infection in critical care unit lecture 2013](https://reader036.vdocuments.site/reader036/viewer/2022062703/55567338d8b42a144c8b526b/html5/thumbnails/59.jpg)
Herpes simplex virus, seen here in the esophagus, infects the squamous epithelium and manifests with
multinucleated cells and inclusions
![Page 60: Viral infection in critical care unit lecture 2013](https://reader036.vdocuments.site/reader036/viewer/2022062703/55567338d8b42a144c8b526b/html5/thumbnails/60.jpg)
Herpes Simplex
HSV can be detected in the lower respiratory tract of 5– 64% of ICU patients.
HSV detection in the lower respiratory tract does not necessarily mean herpetic pulmonary disease. Contamination Local tracheobronchial excretion Real HSV bronchopneumonitis
![Page 61: Viral infection in critical care unit lecture 2013](https://reader036.vdocuments.site/reader036/viewer/2022062703/55567338d8b42a144c8b526b/html5/thumbnails/61.jpg)
Herpes Simplex
The exact role of HSV in ICU patients, that is, as a marker of disease severity or true pathogen with its own morbidity or mortality or both, remains unclear.
Oropharyngeal and tracheobronchial HSV carriage has been associated with prolonged hospital stay and higher mortality.
![Page 62: Viral infection in critical care unit lecture 2013](https://reader036.vdocuments.site/reader036/viewer/2022062703/55567338d8b42a144c8b526b/html5/thumbnails/62.jpg)
Herpes Simplex
Only a randomized trial evaluating
a specific antiviral treatment could
answer such a question.
![Page 63: Viral infection in critical care unit lecture 2013](https://reader036.vdocuments.site/reader036/viewer/2022062703/55567338d8b42a144c8b526b/html5/thumbnails/63.jpg)
CMV infection
• CMV infection occurs in 0 to 36% (median
25%) of critically ill patients between 4 and
12 days after ICU admission, especially
those with sepsis, requiring mechanical
ventilation, and receiving transfusion.
Critical Care 2009, 13:R68 (doi:10.1186/cc7875)
![Page 64: Viral infection in critical care unit lecture 2013](https://reader036.vdocuments.site/reader036/viewer/2022062703/55567338d8b42a144c8b526b/html5/thumbnails/64.jpg)
![Page 65: Viral infection in critical care unit lecture 2013](https://reader036.vdocuments.site/reader036/viewer/2022062703/55567338d8b42a144c8b526b/html5/thumbnails/65.jpg)
Molecular diagnosis of respiratory viruses and its impact on clinical management
![Page 66: Viral infection in critical care unit lecture 2013](https://reader036.vdocuments.site/reader036/viewer/2022062703/55567338d8b42a144c8b526b/html5/thumbnails/66.jpg)
Cell Culture Widely used Result in 7-14
days or longer
![Page 67: Viral infection in critical care unit lecture 2013](https://reader036.vdocuments.site/reader036/viewer/2022062703/55567338d8b42a144c8b526b/html5/thumbnails/67.jpg)
Respiratory Viruses: Diagnosis Pre 1990’s.Advantages Disadvantage
sTissue Culture
“Open” TechniqueSensitiveFurther characterisationEvidence of active infection
Not applicable to allTime consumingviable virus onlyContamination/toxins
Serology Detects current and past infection (immunity)Important for fastidious viruses
Prolonged testing time
Antigen detection
RapidDetects non-viable virusCan test large numbers of samples
Not applicable to allinterference
![Page 68: Viral infection in critical care unit lecture 2013](https://reader036.vdocuments.site/reader036/viewer/2022062703/55567338d8b42a144c8b526b/html5/thumbnails/68.jpg)
DEAFF test for CMV
(Virology Laboratory, Yale-New Haven Hospital)
![Page 69: Viral infection in critical care unit lecture 2013](https://reader036.vdocuments.site/reader036/viewer/2022062703/55567338d8b42a144c8b526b/html5/thumbnails/69.jpg)
Laboratory Diagnosis (2)
1. CMV antigenaemia test - widely used in many European countries. CMV antigens at the surface of polymorphonuclear leukocytes are detected by immunoperoxidase or immunofluorescence techniques. A result can be obtained within 4 to 6 hours but the technique is very tricky.
2. Polymerase chain reaction - becoming the method of choice in a few laboratories, had been reported to carry a higher prognostic value for CMV disease than the DEAFF test. Potential problems with sensitivity.
3. Serology - not reliable in general but occasionally, rises in IgG titre and the presence of IgM may be seen.
![Page 70: Viral infection in critical care unit lecture 2013](https://reader036.vdocuments.site/reader036/viewer/2022062703/55567338d8b42a144c8b526b/html5/thumbnails/70.jpg)
Antigen detection by Immunofluorescence
Rapid Relatively
insensitive Not suitable for all
speciemn types Subjective
![Page 71: Viral infection in critical care unit lecture 2013](https://reader036.vdocuments.site/reader036/viewer/2022062703/55567338d8b42a144c8b526b/html5/thumbnails/71.jpg)
Serology
Technically demanding
InsensitiveAcute and
convalescent serum sample
![Page 72: Viral infection in critical care unit lecture 2013](https://reader036.vdocuments.site/reader036/viewer/2022062703/55567338d8b42a144c8b526b/html5/thumbnails/72.jpg)
Polymerase Chain Reaction (PCR)-Xeroxing DNA! Kary Mullis Won the
NobelPrize in 1993 for describing the methodology in 1985 to replicate DNA in a test tube.
![Page 73: Viral infection in critical care unit lecture 2013](https://reader036.vdocuments.site/reader036/viewer/2022062703/55567338d8b42a144c8b526b/html5/thumbnails/73.jpg)
![Page 74: Viral infection in critical care unit lecture 2013](https://reader036.vdocuments.site/reader036/viewer/2022062703/55567338d8b42a144c8b526b/html5/thumbnails/74.jpg)
PCR
![Page 75: Viral infection in critical care unit lecture 2013](https://reader036.vdocuments.site/reader036/viewer/2022062703/55567338d8b42a144c8b526b/html5/thumbnails/75.jpg)
Viral pneumonia Gives a pattern of
acute injury similar to adult respiratory distress syndrome (ARDS)
Acute inflammatory infiltration less obvious
Viral inclusions sometimes seen in epithelial cells
![Page 76: Viral infection in critical care unit lecture 2013](https://reader036.vdocuments.site/reader036/viewer/2022062703/55567338d8b42a144c8b526b/html5/thumbnails/76.jpg)
![Page 77: Viral infection in critical care unit lecture 2013](https://reader036.vdocuments.site/reader036/viewer/2022062703/55567338d8b42a144c8b526b/html5/thumbnails/77.jpg)
![Page 78: Viral infection in critical care unit lecture 2013](https://reader036.vdocuments.site/reader036/viewer/2022062703/55567338d8b42a144c8b526b/html5/thumbnails/78.jpg)
LIVER
![Page 79: Viral infection in critical care unit lecture 2013](https://reader036.vdocuments.site/reader036/viewer/2022062703/55567338d8b42a144c8b526b/html5/thumbnails/79.jpg)
IMMUNOPEROXIDASE IN LUNG
![Page 80: Viral infection in critical care unit lecture 2013](https://reader036.vdocuments.site/reader036/viewer/2022062703/55567338d8b42a144c8b526b/html5/thumbnails/80.jpg)
CMV
![Page 81: Viral infection in critical care unit lecture 2013](https://reader036.vdocuments.site/reader036/viewer/2022062703/55567338d8b42a144c8b526b/html5/thumbnails/81.jpg)
Management (1)
Ganciclovir - is the drug of choice. However, it is associated with neutropenia and thrombocytopenia.
Forscarnet - can be used as the 2nd line drug. Again it is very toxic and is associated with renal toxicity.
Cifofovir (HPMCC) - approved for the treatment of CMV retinitis. It is also associated with renal toxicity.
Fomivirsen - intravitreal fomivirsen is approved for the treatment of CMV retinitis.
CMV hyperimmune globulin - found to be effective against CMV pneumonitis.
![Page 82: Viral infection in critical care unit lecture 2013](https://reader036.vdocuments.site/reader036/viewer/2022062703/55567338d8b42a144c8b526b/html5/thumbnails/82.jpg)
Management (2)
Transplant Recipients - once clinical disease is established, the patient should be treated vigorously with antiviral agents. Ganciclovir is the drug of choice. CMV hyperimmune globulin had been found to be useful in the treatment of CMV retinitis.
AIDS patient with retinitis - vigorous antiviral therapy should be given. Both systemic and local (intravitreal implants) may be used.
![Page 83: Viral infection in critical care unit lecture 2013](https://reader036.vdocuments.site/reader036/viewer/2022062703/55567338d8b42a144c8b526b/html5/thumbnails/83.jpg)
![Page 84: Viral infection in critical care unit lecture 2013](https://reader036.vdocuments.site/reader036/viewer/2022062703/55567338d8b42a144c8b526b/html5/thumbnails/84.jpg)
2011 California San Diego presentation
![Page 85: Viral infection in critical care unit lecture 2013](https://reader036.vdocuments.site/reader036/viewer/2022062703/55567338d8b42a144c8b526b/html5/thumbnails/85.jpg)
![Page 86: Viral infection in critical care unit lecture 2013](https://reader036.vdocuments.site/reader036/viewer/2022062703/55567338d8b42a144c8b526b/html5/thumbnails/86.jpg)
![Page 87: Viral infection in critical care unit lecture 2013](https://reader036.vdocuments.site/reader036/viewer/2022062703/55567338d8b42a144c8b526b/html5/thumbnails/87.jpg)